CCEP: Derechos Humanos C3
21 CFR Part 312 vs 21 CFR Part 812 - correct answer-21 CFR Part 312 = FDA Form
1572, Serious Adverse Event
21 CFR Part 812 = Investigational agreement, Unanticipated Adverse Device Effects
21 CFR Part 312.34 - correct answer-Treatment use of an Investigational new drug
21 CFR Part 812 - correct answer-Investigational Device Exemption
21 CFR Part 814 - correct answer-Premarket approval of medical devices
Class I (device) - correct answer-Lowest risk
--General controls are sufficient to provider reasonable assurance of the safety and
effectiveness
Ex. powered wheelchairs, infusion pumps, and surgical drapes
Class II (device) - correct answer-Moderate risk, usually requires a 510k (pre-market
submission made to FDA)
--General controls are insufficient to assure safety and effectiveness
--Special controls include: special labeling requirements, mandatory performance
standards, post-market surveillance
Ex. powered wheelchairs, infusion pumps, and surgical drapes
Class III (device) - correct answer-Highest risk, usually requires a 510k (pre-market
submission made to FDA)
-Usually those that support or sustain human life
-Important for preventing impairment of human health
-Present a potential risk of illness or injury
Ex. implant, used in supporting or sustaining human life
During which phases is a treatment protocol usually made available? - correct
answer-During Phase 3 but if data is compelling, may be available during Phase 2,
OR, after all clinical trials have been completed and Sponsor of trials is
awaiting/pursuing marketing approval
Equity interest in publicly traded company greater than $____ should be reported? -
correct answer-$50,000
Exemption for investigation of a device: Abbreviated Requirements (21 CFR Part
812.2[c]) - correct answer-Categories of investigations considered to have approved
IDE applications, unless FDA has notified sponsor otherwise
, -Those in use in accordance with its labeling & in commercial distribution before
5/28/1976
-A diagnostic device if the testing is:
--noninvasive
--does not require invasive sampling of significant risk
--does not introduce energy into subjects, and,
--is not used as a diagnostic procedure without confirmation by another medically
established diagnostic product/procedure
-Device undergoing consumer preference testing modification testing, or combo of
2/more devices in commercial distribution
-Device solely for veterinary use or lab animal research
How long is the reporting period for equity interest and significant payments? -
correct answer-Study period plus one year
How long is the waiting period before a treatment IND study can be initiated? -
correct answer-30 days
How many days after FDA receives IND submission does the IND go into effect? (21
CFR 312.40) - correct answer-An IND goes into effect 30 days after the FDA
receives the submission unless the FDA notifies the Sponsor of a clinical hold
How many days do you have to report a deviation from an investigational device plan
to Sponsor and IRB, and why? - correct answer-Five days. Deviations are to protect
human life or physical well-being
How many days do you have to report an unanticipated adverse device effect? -
correct answer-As soon as possible, but no later than 10 days after Investigator first
learns of the event
How many days does a Physician or Sponsor have to submit written summary of
expanded access to the FDA after use? - correct answer-15 days
IDE (Investigational Device Exemption) - correct answer-An approved IDE permits
device to be shipped lawfully
Medical device - correct answer-Device is NOT dependent on chemical action or
being metabolized and;
-also must be recognized in official national formulary or US pharmacopoeia
-intended for use in the diagnosis, treatment, mitigation or prevention of disease in
man or other animals
Minimal risk - correct answer-The likelihood of harm is no greater than that
encountered in daily life or during routine PE
Voordelen van het kopen van samenvattingen bij Stuvia op een rij:
√ Verzekerd van kwaliteit door reviews
Stuvia-klanten hebben meer dan 700.000 samenvattingen beoordeeld. Zo weet je zeker dat je de beste documenten koopt!
Snel en makkelijk kopen
Je betaalt supersnel en eenmalig met iDeal, Bancontact of creditcard voor de samenvatting. Zonder lidmaatschap.
Focus op de essentie
Samenvattingen worden geschreven voor en door anderen. Daarom zijn de samenvattingen altijd betrouwbaar en actueel. Zo kom je snel tot de kern!
Veelgestelde vragen
Wat krijg ik als ik dit document koop?
Je krijgt een PDF, die direct beschikbaar is na je aankoop. Het gekochte document is altijd, overal en oneindig toegankelijk via je profiel.
Tevredenheidsgarantie: hoe werkt dat?
Onze tevredenheidsgarantie zorgt ervoor dat je altijd een studiedocument vindt dat goed bij je past. Je vult een formulier in en onze klantenservice regelt de rest.
Van wie koop ik deze samenvatting?
Stuvia is een marktplaats, je koop dit document dus niet van ons, maar van verkoper Hkane. Stuvia faciliteert de betaling aan de verkoper.
Zit ik meteen vast aan een abonnement?
Nee, je koopt alleen deze samenvatting voor €7,77. Je zit daarna nergens aan vast.
